9.10 -0.62 (-6.38%)
After hours: 6:03PM EST
Previous close | 10.10 |
Open | 10.13 |
Bid | 9.31 x 2200 |
Ask | 9.06 x 800 |
Day's range | 9.67 - 10.28 |
52-week range | 3.14 - 33.79 |
Volume | 6,487,375 |
Avg. volume | 10,709,927 |
Market cap | 1.647B |
Beta (5Y monthly) | 1.08 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.32 |
Earnings date | 09 Nov 2020 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 12.29 |
This coronavirus vaccine drugmaker has already made many of its early investors rich, but its valuation is still dirt cheap.
Analysts have very different takes on the early-stage results for the company's COVID-19 vaccine candidate.